Skip to main content

Study

Stem Cells May Relieve Pain and Improve Function in Seniors with Knee Osteoarthritis

New research suggests mesenchymal stem cells could help reduce pain and improve knee function in seniors with osteoarthritis.

Joint HealthPain ManagementHealthy Aging
Study Credibility: High8.1/10From a trusted journalProperly designed studyResults verified
PublishedMar 2026Last reviewedOct 2026
Email this

Summary

In plain language

Recent research has shown that mesenchymal stem cells (MSCs) might help reduce pain and improve knee function for individuals suffering from osteoarthritis, particularly seniors. The study reviewed several trials and found that MSCs were more effective than standard treatments in alleviating pain and improving joint function over a 12-month period. Osteoarthritis is a common issue among older adults, leading to joint pain and reduced mobility. This study offers hope for non-surgical treatment options that could improve quality of life for those affected. However, more long-term research is needed to fully understand the benefits and safety of using stem cells for this purpose.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study reviewed several trials where seniors with knee osteoarthritis were given mesenchymal stem cells. Here's what you should know:

  • Researchers compared stem cells to a placebo and observed improvements in pain relief and knee function after 12 months.

  • The study included 18 trials and found that stem cells were generally safe, with no significant increase in adverse effects compared to placebo.

  • However, the trials varied widely, and long-term benefits are still unclear, so more research is needed.

If you're dealing with osteoarthritis, this new treatment might offer hope. Discuss with your healthcare provider whether stem cell therapy could be an option for your knee pain.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scored highly due to its rigorous systematic review and meta-analysis design, comprehensive bias control measures, and adherence to PRISMA guidelines. The absence of conflicts of interest and alignment with the target population further strengthened its score. However, the lack of replication evidence and moderate journal quality slightly reduced the overall score.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control6.7/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

This systematic review and meta-analysis evaluated the efficacy and safety of mesenchymal stem cells (MSCs) for knee osteoarthritis, finding MSCs superior to placebo in pain relief and function improvement at 12 months, with no significant increase in adverse events.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.